lateral flow
The company is commercializing a test with five biomarkers it believes can be used to accurately predict the presence of lung cancer in urine.
The move to discontinue free testing has concerned some experts, who charge it is more of a political decision than a scientific one.
BioLytical Laboratories Nabs Health Canada Interim Order Authorization for At-Home COVID-19 Test
The at-home antigen test is the second COVID-19 antigen assay authorized by Health Canada that BioLytical is launching with its iStatis lateral flow platform.
BioLytical Laboratories Receives CE Marking for COVID-19 Antigen Test
The at-home antigen test is portable and has been 100 percent accurate in clinical studies, the company said.
The company formally introduced its SimpleTest 2 at HIMSS22 this week because the firm wants to play up the cloud-linked product's data management and interoperability features.
Jan 20, 2022
Dec 2, 2021
Jul 28, 2021